from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0803/purL

LFCtreatmentdescriptionclass of inhibitor

0.054

Amikacinug/mL Amikacintranslation

-0.368

Cap5-10ug/mL Capreomycintranslation

-1.608

Rox10-50 ug/mL Roxithromycintranslation

-0.127

SM2-5 ug/mL Streptomycintranslation

-2.514

Tet5-10 ug/mL Tetracyclinetranslation

0.744

Rif0.2-5ug/mL Rifampicintranscription

0.304

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.101

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.038

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.508

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.958

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.119

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.021

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.158

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.499

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.479

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.335

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.324

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.756

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.190

KCN5-20 ug/mL Potassium cyaniderespiration

0.147

NaN30.2-2 mM Sodium aziderespiration

1.384

Nigericin50 uM Nigericinrespiration

-1.134

TRC10-150 ug/mL Triclosanrespiration

-0.750

TRZ10-25 ug/mL Thioridazinerespiration

-0.003

Valinomycin0.5-10 uM Valinomycinrespiration

-0.060

ZnSO42 mM ZnSO4respiration

2.996

menadione6-10 ug/mL Menadionerespiration

-0.121

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.534

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.062

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.729

NRP_1Non-replicating persistence stage 1dosRassociated

0.335

Amp0.2mg/mL AmpicillincellWall

0.708

Cephalexin20-100 ug/mL CephalexincellWall

0.234

Cerulenin0.32-5 ug/mL CerulenincellWall

0.707

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.189

EMB10-20 ug/mL EthambutolcellWall

0.633

Eta12-40 ug/mL EthionamidecellWall

0.643

INH0.2-0.4 ug/mL IsoniazidcellWall

0.403

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.724

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.527

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.107

BZA0.12 mg/mL BenzamidearomaticAmides

0.139

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.106

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.107

H2O24 mM hydrogen peroxideDNAdamaging

0.189

Levo10 ug/mL LevofloxacinDNAdamaging

0.404

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.667

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.346

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.615

UVUV-irradiationDNAdamaging

0.396

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.077

Antimycin12.5-50 ug/mL Antimycin A?

0.197

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.055

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.392

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.819

PA8240.2-2 ug/mL PA-824?

0.423

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.341

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.811

Verapamil50 uM Verapamil?

-0.195

mercaptoethanol2 mM 2-Mercaptoethanol?

0.586

methoxatin10-20 ug/mL Methoxatin?